The initial public offering (IPO) window may be creaking open for biotech – thanks in part to the new emerging growth company designation included in last year's JOBS Act – but running a publicly listed small biotech requires as much dedication as ever. Read More
LONDON – A new study has connected known differences in the metabolism typical of cancer cells to the pathway leading to apoptosis, or cell death. Researchers working in Finland have, for the first time, linked metabolic changes in cancer cells to the mechanism that, in normal cells, prevents abnormal cellular proliferation. Read More
Congress is running out of patience with the SEC's continued delay in implementing part of the Jumpstart Our Business Startups (JOBS) Act that was supposed to be in place last year. Read More
• Armgo Pharma Inc., of Tarrytown, N.Y., and the Muscular Dystrophy Association (MDA) said $1 million was awarded for preclinical work in support of an investigational new drug application for AMR201, an oral, small-molecule Rycal drug that has the potential to treat Duchenne's muscular dystrophy. Read More
• Medicago Inc., of Quebec City, and the Infectious Disease Research Institute (IDRI) in Seattle reported interim results from a Phase I trial testing an H5N1 avian influenza virus-like particle vaccine candidate, showing that it was safe and well tolerated and induced a solid immune response exceeding the three Committee for Medicinal Products for Human Use immunogenicity criteria for licensure of influenza vaccines. Read More
• Cipla Ltd., of Mumbai, India, said it launched the first biosimilar of etanercept in India, under the brand name Etacept, for the treatment of rheumatic disorders. Read More
